Morinaga & Co AI Stock Analysis
Want to see JP:2201 full AI Analyst Report?
Morinaga & Co (2201) AI Stock Analysis
Morinaga & Co
(TSE/TYO:2201)
The score is primarily supported by solid financial performance (steady growth, decent margins, conservative leverage), but is held back by volatile cash-flow conversion and weak technical trends (trading below key moving averages with negative MACD). Valuation is a positive offset with a moderate P/E and a ~2.55% dividend yield.
Morinaga & Co (2201) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 1.30B
- Dividend Yield
- 2.66%
- Average Volume (3M)
- 349.82K
- Price to Earnings (P/E)
- 14.0
- Beta (1Y)
- 0.17
- Revenue Growth
- 5.05%
- EPS Growth
- -14.89%
- Country
- Japan
- Employees
- 3,222
- Sector
- General
- Sector Strength
- 55
- Industry
- Food Confectioners
Morinaga & Co Business Overview & Revenue Model
Company Description
Established in Tokyo, Japan, in 1899, Morinaga&Co., Ltd. is a prominent manufacturer, procurer, and distributor of a broad array of consumer products, serving markets both within Japan and internationally. The company's diverse offerings span confect...
How the Company Makes Money
Morinaga & Co. makes money mainly by manufacturing and selling branded packaged foods, with revenue recognized from product sales to wholesalers, retailers, and other business customers. Its core revenue stream is confectionery: it earns sales from h...
Morinaga & Co Earnings Call Summary
The earnings call highlighted significant growth in net sales and strong performance in key segments like the U.S. business and Frozen Desserts. Strategic initiatives and successful market expansions are positive indicators for future growth. However, challenges such as increased costs, expected profit declines in H2, and pressure on profit margins due to raw material costs present notable challenges. The overall sentiment is cautiously optimistic with a recognition of areas requiring attention.
Q2-2024 Updates
Positive Updates
Negative Updates
Company Guidance
In the earnings call for Q2 of the fiscal year ending March 2024, Eijiro Oota, the executive of 2201.T, reported impressive financial results, with net sales reaching JPY 109.6 billion, which is JPY 11.2 billion higher than the previous year and JPY 3.6 billion above the forecast. Operating income was JPY 14.1 billion, surpassing the previous year by JPY 3.9 billion and exceeding the forecast by JPY 2.2 billion, resulting in an operating margin of 12.9%. The U.S. business significantly contributed to earnings growth, amid a JPY 2.9 billion impact from increased raw materials and energy costs. The company forecasts net sales of JPY 210 billion for the fiscal year, indicating a JPY 15.7 billion increase from the previous year. Despite anticipating decreased profits in H2 due to increased strategic investments and advertising, the firm expects an operating income of JPY 18.7 billion and net income of JPY 13.6 billion, both surpassing previous year figures. Furthermore, the ratio of overseas sales to total sales is projected to exceed the midterm target, supported by strong growth in the U.S. market.
Morinaga & Co Financial Statement Overview
Summary
Steady revenue growth from 2023–2026 and improving profitability versus 2023 support a solid core profile, while low leverage and rising equity add resilience. The main constraint is volatile operating/free cash flow and weak, inconsistent cash conversion (e.g., 2026 FCF only ~28% of net income), which lowers overall quality.
Income Statement
74PositiveBalance Sheet
82Very PositiveCash Flow
58Neutral| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 234.01B | 228.96B | 236.67B | 213.37B | 194.37B | 181.25B |
| Gross Profit | 92.66B | 90.02B | 94.96B | 86.65B | 76.57B | 75.71B |
| EBITDA | 36.80B | 34.31B | 35.62B | 30.17B | 24.18B | 49.38B |
| Net Income | 19.66B | 17.71B | 17.77B | 15.15B | 10.06B | 27.77B |
Balance Sheet | ||||||
| Total Assets | 221.90B | 209.99B | 225.92B | 223.64B | 205.23B | 220.87B |
| Cash, Cash Equivalents and Short-Term Investments | 24.55B | 31.06B | 26.42B | 49.90B | 36.36B | 60.33B |
| Total Debt | 21.00B | 20.19B | 20.05B | 20.32B | 20.44B | 10.98B |
| Total Liabilities | 85.83B | 77.59B | 82.22B | 90.99B | 79.37B | 89.70B |
| Stockholders Equity | 134.38B | 130.87B | 141.96B | 131.20B | 124.57B | 130.03B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -2.82B | 6.65B | 21.08B | -16.27B | 9.52B |
| Operating Cash Flow | 0 | 10.76B | 23.64B | 30.17B | -2.97B | 24.82B |
| Investing Cash Flow | 0 | -9.84B | -14.29B | -5.34B | -14.21B | 9.31B |
| Financing Cash Flow | 0 | -18.01B | -13.24B | -14.07B | -7.35B | -5.94B |
Morinaga & Co Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2201, the sentiment is Positive. The current price of 2537.50 is above the 20-day moving average (MA) of 2447.70, above the 50-day MA of 2434.24, and below the 200-day MA of 2567.93, indicating a neutral trend. The MACD of 17.98 indicates Negative momentum. The RSI at 59.66 is Neutral, neither overbought nor oversold. The STOCH value of 61.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2201.
Morinaga & Co Peers Comparison
Overall Rating
JP:221678Outperform
JP:220875Outperform
JP:220166Neutral
JP:220966Neutral
JP:221748.9Neutral
JP:221147Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | JPY 45.01B | 15.32 | ― | 3.01% | 7.25% | -11.18% | |
| 75Outperform | JPY 73.03B | 11.54 | ― | 1.45% | 7.47% | 27.86% | |
| 66Neutral | JPY 208.63B | 13.98 | 10.76% | 2.66% | 5.05% | -14.89% | |
| 66Neutral | JPY 29.26B | 15.31 | ― | 1.70% | 1.80% | -27.32% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 49Neutral | JPY 28.66B | 65.64 | ― | 1.07% | 1.95% | -63.95% | |
| 47Neutral | JPY 62.38B | 52.86 | ― | 1.24% | 5.76% | -38.25% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2201 | Morinaga & Co | 2537.50 | -35.68 | -1.39% | |
| JP:2208 | Bourbon Corporation | 3040.00 | 670.91 | 28.32% | |
| JP:2209 | Imuraya Group Co., Ltd. | 2236.00 | -261.64 | -10.48% | |
| JP:2211 | Fujiya Co., Ltd. | 2420.00 | -167.46 | -6.47% | |
| JP:2216 | KANRO Co., Ltd. | 1063.00 | -434.39 | -29.01% | |
| JP:2217 | Morozoff Limited | 1404.00 | -114.60 | -7.55% |
Morinaga & Co Corporate Events
Morinaga & Co. Posts Higher Sales but Lower Profit in First Quarter, Raises Dividend Outlook
Morinaga & Co. reported a 5.6% year-on-year rise in net sales to ¥63.6 billion for the three months ended June 30, 2026, but saw operating income fall 13.7% to ¥6.1 billion and profit attributable to owners of parent decline 11.7% to ¥4.5 billion. De...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026
